Orin
ARESNYSE·Asset Management

Ares Management Corporation ARES

Market cap $39.5BP/E 52.4× trailingGross margin 62.7%Reports Mon 2 Nov, before the open
$120.27
+0.16 (+0.13%)live 11:25 ET
52-wk $95.80 – $181.19
Watch
Orin's take
0.62conviction · moderate
Refreshed 26 Aug · take v8. A new filing or a print queues the next refresh.

Ares Management's FY2025 revenue surged 66.5% to $6.47B with $3.19B in free cash flow, and Q2 2026 results confirmed record fundraising and double-digit fee-related earnings growth — but diluted EPS still declined 5.3% to $1.96, signaling that share dilution is absorbing much of the operational gain. The stock trades at 62.3x trailing earnings, a 258% premium to the peer median of 17.4x, and insiders have sold a net $763.8M of stock over 24 months including CEO Arougheti's June 30 sale of 82,957 shares at $111.31.

With smart money essentially flat (-0.0064 as of Q2 2026) and MACD turning negative, the strong fundamentals are already more than fully priced in.

What could go wrong

  • Valuation compression. At 62.3x earnings versus a peer median of 17.4x, any disappointment in fundraising or fee-related earnings could trigger a sharp de-rating given the premium multiple.
  • Persistent insider selling. Net insider dispositions of 4.77M shares worth $763.8M over 24 months, with 193 sales versus 25 acquisitions, signal that management may not view current levels as attractive entry points.
  • EPS dilution despite revenue growth. FY2025 revenue grew 66.5% yet EPS fell from $2.07 to $1.96, indicating share count expansion or margin pressure that could persist if equity-based compensation continues accelerating.
  • High leverage. Total debt of $14.9B against stockholders' equity of $4.3B as of FY2025 creates balance-sheet sensitivity in a credit downturn, particularly given Ares's direct lending exposure.

What would change my mind

AUM and FRE growth acceleration. Quarterly fee-related earnings growth exceeds 20% YoY with rising AUM and stable or declining share countbullish
Insider buying reversal. Net insider transactions turn positive over a 3-month window, especially by executive officersbullish
Multiple compression on earnings miss. ARES misses quarterly FRE or AUM estimates and the stock breaks below the 200-day MA of $133.60bearish

Where this comes from: FMP annual fundamentals + derived_metrics FY2025 · FMP annual fundamentals + derived_metrics FY2025 · FMP annual fundamentals FY2025 · peer_relative composite. Orin's read on ARES; not advice.

Twelve months actual closes to 2026-09-24 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Vanguard Capital Management$1.5B0.0% of fund
Bank Of America /De/$1.3B0.1% of fund
Vanguard Portfolio Management$1.2B0.1% of fund
Capital World Investors$1.2B0.1% of fund
Wellington Management Group Llp$1.1B0.2% of fund
State Street$999.4M0.0% of fund

87 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 218 Form 4 filings, net −$763.8M. Of the 50 on hand, 2 were open-market purchases and 20 sales— the rest are grants, option exercises and tax withholding.

Ask Orin about ARES

its filings · its transcripts · its numbers

Orin answers questions about ARES from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days →

Where it trades

vs its own 5y · Financial Services
MetricNowOwn medianSector
P/E52.4×66.6×21.6×
EV/EBITDA21.1×22.6×—
P/S6.18×5.43×—
P/B6.9×8.2×—

Its P/E sits 40th percentile of its own last 5 years (−0.37σ from its own mean).

What the price assumes

1.1%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $3.2B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

22 firms · 2026-09-24
Consensus target

$149

$134 – $168 · +24% against today's price

How they rate it
  • 17 buy or overweight
  • 5 hold
  • 0 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 15.8× of 7 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
ARESAres Management Corporation$39B52.4×21.1×62.7%10.0%15%
APOApollo Global Management, Inc.$70B26.1×6.0×84.5%5.2%9%
BROBrown & Brown, Inc.$20B16.7×11.2×59.0%17.6%10%
HBANHuntington Bancshares Incorporated$31B11.3×14.2×63.7%16.6%9%
MSMorgan Stanley$310B15.8×23.0×59.7%16.0%18%
RJFRaymond James Financial, Inc.$30B13.6×7.9×83.5%13.6%18%
SOFISoFi Technologies, Inc.$22B32.9×23.5×76.5%11.4%6%
STTState Street Corporation$50B15.7×14.8×65.3%15.0%12%

The median is of the 7 peers listed above and nothing else — check it against the column. This company trades 232.3% above it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY14 39.9×FY25 82.5×

What its sector has traded at

Financial Services
FY14 29.6×FY26 23.8×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Discounted cash flow

not recomputed since
ModelFair valueAgainstComputed
Standard DCF$91$129.24 · −29%2026-06-10
Levered DCF$-20$129.24 · −116%2026-06-10

The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.

Every estimate on one scale

price $120.27
52-week range$96 – $181
Analyst targets$134 – $168
Standard DCF$91 as of 2026-06-10, when it was $129.24
Levered DCF$-20 as of 2026-06-10, when it was $129.24
At own 5y-median P/E (67×)$153
At 5y P/E range (33–76×)$75 – $173
At sector P/E (22×)$49

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.